Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study - PubMed (original) (raw)
Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study
Anthony J G Hanley et al. Diabetes Care. 2002 Jul.
Abstract
Objective: The prospective association between insulin levels and risk of cardiovascular disease (CVD) is controversial. The objective of the present study was to investigate the relationship of the homeostasis model assessment of insulin resistance (HOMA-IR), as well as insulin levels, with risk of nonfatal and fatal CVD over the 8-year follow-up of the San Antonio Heart Study.
Research design and methods: Between 1984 and 1988, randomly selected Mexican-American and non-Hispanic white residents of San Antonio participated in baseline examinations that included fasting blood samples for glucose, insulin, and lipids, a glucose tolerance test, anthropometric measurements, and a lifestyle questionnaire. Between 1991 and 1996, 2,569 subjects who were free of diabetes at baseline were reexamined using the same protocol.
Results: Over the follow-up period, 187 subjects experienced an incident cardiovascular event (heart attack, stroke, heart surgery, angina, or CVD death). Logistic regression analysis indicated that risk of a CVD event increased across quintiles of HOMA-IR after adjustment for age, sex, and ethnicity (P for trend <0.0001; quintile 5 vs. quintile 1, odds ratio [OR] 2.52, 95% CI 1.46-4.36). Additional adjustment for LDL, triglyceride, HDL, systolic blood pressure, smoking, alcohol consumption, exercise, and waist circumference only modestly reduced the magnitude of these associations (P for trend 0.02; quintile 5 vs. quintile 1, OR 1.94, 95% CI 1.05-3.59). Furthermore, there were no significant interactions between HOMA-IR and ethnicity, sex, hypertension, dyslipidemia, glucose tolerance (impaired glucose tolerance versus normal glucose tolerance), or obesity. The magnitude and direction of the relationship between insulin concentration and incident CVD were similar.
Conclusions: We found a significant association between HOMA-IR and risk of CVD after adjustment for multiple covariates. The topic remains controversial, however, and additional studies are required, particularly among women and minority populations.
Similar articles
- HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study.
Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Cacciatori V, Santi L, Targher G, Bonadonna R, Muggeo M. Bonora E, et al. Diabetes Care. 2002 Jul;25(7):1135-41. doi: 10.2337/diacare.25.7.1135. Diabetes Care. 2002. PMID: 12087010 - The homeostasis model in the San Antonio Heart Study.
Haffner SM, Miettinen H, Stern MP. Haffner SM, et al. Diabetes Care. 1997 Jul;20(7):1087-92. doi: 10.2337/diacare.20.7.1087. Diabetes Care. 1997. PMID: 9203442 - Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
Amoah AG, Schuster DP, Gaillard T, Osei K. Amoah AG, et al. Ethn Dis. 2002 Fall;12(4):S3-10-7. Ethn Dis. 2002. PMID: 12477148 - Effects of Light Intensity Activity on CVD Risk Factors: A Systematic Review of Intervention Studies.
Batacan RB Jr, Duncan MJ, Dalbo VJ, Tucker PS, Fenning AS. Batacan RB Jr, et al. Biomed Res Int. 2015;2015:596367. doi: 10.1155/2015/596367. Epub 2015 Oct 12. Biomed Res Int. 2015. PMID: 26543862 Free PMC article. Review. - Insulin resistance and cardiovascular disease.
Kosmas CE, Bousvarou MD, Kostara CE, Papakonstantinou EJ, Salamou E, Guzman E. Kosmas CE, et al. J Int Med Res. 2023 Mar;51(3):3000605231164548. doi: 10.1177/03000605231164548. J Int Med Res. 2023. PMID: 36994866 Free PMC article. Review.
Cited by
- The correlation between HOMA-IR and cardiometabolic risk index among different metabolic adults: a cross-sectional study.
Lu Q, Chen B, Li A, Liang Q, Yao J, Tao Y, Dai F, Hu X, Lu J, Liu Y, Liu Y, Wang Y, Long J, Zhang R, Liu Z. Lu Q, et al. Acta Diabetol. 2024 Aug 9. doi: 10.1007/s00592-024-02332-y. Online ahead of print. Acta Diabetol. 2024. PMID: 39122878 - Prevalence and contributing factors of metabolic syndrome in rheumatoid arthritis patients.
Bagheri-Hosseinabadi Z, Moadab F, Abbasifard M. Bagheri-Hosseinabadi Z, et al. BMC Endocr Disord. 2024 Aug 5;24(1):140. doi: 10.1186/s12902-024-01675-5. BMC Endocr Disord. 2024. PMID: 39103813 Free PMC article. - Physical Activity, Cardiovascular Status, Mortality, and Prediabetes in Hispanic and Non-Hispanic Adults.
Alver SK, Pan S, Mossavar-Rahmani Y, Sotres-Alvarez D, Evenson KR, Floyd JS, Xanthakis V, Lin J, Cuthbertson C, Gallo LC, Cai J, Penedo FJ, Llabre MM, Matsushita K, Talavera GA, Pirzada A, Spartano N, Daviglus ML, Vasan RS, Kaplan RC. Alver SK, et al. JAMA Netw Open. 2024 Jun 3;7(6):e2415094. doi: 10.1001/jamanetworkopen.2024.15094. JAMA Netw Open. 2024. PMID: 38842811 Free PMC article. - A Nonlinear Relation between Body Mass Index and Long-Term Poststroke Functional Outcome-The Importance of Insulin Resistance, Inflammation, and Insulin-like Growth Factor-Binding Protein-1.
Gadd G, Åberg D, Wall A, Zetterberg H, Blennow K, Jood K, Jern C, Isgaard J, Svensson J, Åberg ND. Gadd G, et al. Int J Mol Sci. 2024 Apr 30;25(9):4931. doi: 10.3390/ijms25094931. Int J Mol Sci. 2024. PMID: 38732147 Free PMC article. - Unexplained Residual Risk In Type 2 Diabetes: How Big Is The Problem?
Neppala S, Rajan J, Yang E, DeFronzo RA. Neppala S, et al. Curr Cardiol Rep. 2024 Jun;26(6):623-633. doi: 10.1007/s11886-024-02055-0. Epub 2024 Apr 18. Curr Cardiol Rep. 2024. PMID: 38634964 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources